China Jo-Jo Drugstores, Inc.

NasdaqCM CJJD

China Jo-Jo Drugstores, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024: USD -2.76 M

China Jo-Jo Drugstores, Inc. EBITDA is USD -2.76 M for the Trailing 12 Months (TTM) ending March 31, 2024, a 86.34% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • China Jo-Jo Drugstores, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -20.23 M, a -931.78% change year over year.
  • China Jo-Jo Drugstores, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -1.96 M, a 67.74% change year over year.
  • China Jo-Jo Drugstores, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -6.08 M, a -100.16% change year over year.
  • China Jo-Jo Drugstores, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2020 was USD -3.04 M, a -472.95% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
NasdaqCM: CJJD

China Jo-Jo Drugstores, Inc.

CEO Mr. Lei Liu M.D.
IPO Date Oct. 1, 2009
Location China
Headquarters Hai Wai Hai Tongxin Mansion
Employees 939
Sector Health Care
Industries
Description

China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2021, it had 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.

Similar companies

PETS

PetMed Express, Inc.

USD 4.88

0.62%

LFLY

Leafly Holdings, Inc.

USD 1.41

0.71%

WBA

Walgreens Boots Alliance, Inc.

USD 12.24

2.86%

StockViz Staff

January 15, 2025

Any question? Send us an email